Epizyme Inc
EPZM
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$2.44
66.3% upside
Current Fair Value
66.3% upsideUndervalued by 66.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $167.10 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.49 |
| Beta | -0.42 |
| Outstanding Shares | 166,990,000 |
Return
| Return on Equity | 1053.76% |
|---|---|
| Return on Assets | -80.90% |
| Return on Invested Capital | -80.10% |
Valuation & Multiples
| P/E Ratio | -0.59 |
|---|---|
| PEG | 1.68 |
| Price to Sales | - |
| Price to Book Ratio | -1.47 |
| Enterprise Value to Revenue | 3.15 |
| Enterprise Value to EBIT | -0.91 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.43 |
| Debt to Equity | -11.74 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Epizyme Inc
CEO: Robert Bazemore